Biomarkers such as PD-L1 expression, microsatellite instability (MSI), tumor mutational burden (TMB), and tumor-infiltrating lymphocyte (TIL) density have been extensively investigated as predictors of responsiveness to ICIs in HCC [47,48]. Here, CD274 is linked to hepatocellular carcinoma.